British drugmaker GlaxoSmithKline has begun producing millions of doses of a new coronavirus vaccine which could come available early next year.
Roger Connor, GSK's president of global vaccines, revealed that mass production of the vaccine was already underway and was now set to move into the final stage of trials.
It comes after Pfizer gave the world fresh hope for a vaccine when it announced its experimental jab was more than 90 per cent effective in preventing the disease.
The UK has bought up 40 million doses of the jab which could be rolled out to the most vulnerable before Christmas. And last night it emerged that tens of millions of UK-made coronavirus vaccines will be ready for production by the end of the year, claims a professor